Telehealth for Discharge Outcomes in Children (TeleDOC)

September 19, 2024 updated by: University of California, Davis

Telehealth for Discharge Outcomes in Children: A Feasibility Study

This study will test the feasibility of a telehealth follow-up visit for patients and their caregivers who were recently discharged from a general pediatric inpatient unit.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

Patient transitions from hospital to home have increasingly become recognized as a critical opportunity to promote patient safety and high quality care, both at University of California Davis Medical Center and nationwide. With over 16,000 children discharged from U.S. hospitals each day and a rate of 1 in 5 experiencing adverse events related to this process, it is estimated that hospital-to-home transition-related adverse events affect over 1.1 million children annually. The quality of hospital discharge also affects hospital readmission rates, length of hospital stay, and parental satisfaction.

Discharge transition difficulties stem largely from care coordination failures throughout the hospital-to-home transition. The investigators recently conducted a qualitative study analyzing perspectives from parents and physicians of 20 children readmitted within 30 days of hospital discharge. The study identified a theme of caregivers having difficulty re-connecting to the child's medical team for ongoing care after discharge. When problems arose, caregivers reported challenges in knowing who to contact, when to reach out for help, and how to navigate the health system to prevent readmission.

The advent of telehealth presents a unique opportunity to provide seamless follow-up for families following hospital discharge. Although telehealth has not previously been studied as a means of providing pediatric follow-up care after hospital discharge, similar methods of providing post-discharge hospital follow-up, including nurse- or physician-led phone calls and nurse home visits, were highly regarded by families, but failed to impact readmission rates. Telehealth provides a unique advantage over these alternate interventions by allowing face-to-face interaction via videoconference between the patient, caregiver, and hospital physician, who is already familiar with the patient's disease course and overall trajectory. At the investigators' site, although telehealth is readily available for use in most any clinical setting, it is not commonly used for hospital discharge follow-up. Therefore, this study proposes to test the feasibility of a telehealth follow-up visit for patients and their caregivers who were recently discharged from a general pediatric inpatient unit.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study will conduct surveys and interviews to evaluate the feasibility of a telehealth follow-up visit between parents/guardians and pediatric hospitalists of children discharged from the University of California Davis Children's Hospital's pediatric hospitalist service. Telehealth follow-up visits will be offered to discharging pediatric patients at the discretion of the pediatric hospitalist who is discharging the patient.

Description

Inclusion Criteria:

  • Parents/legal guardians of patients recently discharged from the University of California Davis Children's Hospital pediatric hospitalist service, who were offered a telehealth follow-up visit following their child's discharge
  • Pediatric hospitalists who discharged the above patients and offered a telehealth follow-up visit following discharge

Exclusion Criteria:

• Parents/legal guardians of children discharged from an intensive care or subspecialty service

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Telehealth
Patients/Caregivers who received a telehealth follow-up visit from a pediatric hospitalist following hospital discharge.
A telehealth follow-up visit will be conducted via the Epic electronic medical record with a pediatric hospitalist following hospital discharge.
Usual Care
Patients/Caregivers who did not receive a telehealth follow-up visit from a pediatric hospitalist following hospital discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility Objective 1: Telehealth visit offered on hospital discharge
Time Frame: Within 7 days of hospital discharge
This objective will assess what percentage of patients discharged from the pediatric hospital medicine service were offered a telehealth follow-up visit on hospital discharge.
Within 7 days of hospital discharge
Feasibility Objective 2: Parent agreement to engage in telehealth visit
Time Frame: Within 7 days of hospital discharge
This objective will assess what percentage of parents who were offered a telehealth visit following hospital discharge agreed to participate.
Within 7 days of hospital discharge
Feasibility Objective 3: Successful completion of telehealth
Time Frame: Within 14 days of hospital discharge
This objective will assess what percentage of scheduled telehealth visits were successfully completed, as reported by the involved pediatric hospitalist.
Within 14 days of hospital discharge
Feasibility Objective 4: Lack of technical issues
Time Frame: Within 14 days of hospital discharge
This objective will assess what percentage of scheduled telehealth visits had not technical issues, as reported by both the involved pediatric hospitalist and the involved caregiver.
Within 14 days of hospital discharge
Feasibility Objective 5: Survey response rates
Time Frame: Within 30 days of hospital discharge
This objective will assess what percentage of surveys administered to both pediatric hospitalists and caregivers were completed.
Within 30 days of hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Readmission
Time Frame: Within 30 days of hospital discharge
This secondary outcome will assess 30-day hospital re-admission rates, by parental report.
Within 30 days of hospital discharge
Hospital Length of Stay
Time Frame: Within 7 days of hospital discharge
This secondary outcome will assess hospital length of stay. This information will be extracted from the electronic medical record.
Within 7 days of hospital discharge
3-Item Care Transitions Measure
Time Frame: Within 30 days of hospital discharge
This secondary outcome will evaluate parent scores on the 3-item Care Transitions Measure, reflecting on their child's recent care transition from hospital to home. The 3-question survey include 4 answer choices from 1 (strongly disagree) to 4 (strongly agree), with higher scores indicated a better outcome.
Within 30 days of hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2023

Primary Completion (Estimated)

May 1, 2023

Study Completion (Actual)

May 1, 2023

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

December 1, 2021

First Posted (Actual)

December 14, 2021

Study Record Updates

Last Update Posted (Actual)

September 23, 2024

Last Update Submitted That Met QC Criteria

September 19, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 1845410

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telehealth

Clinical Trials on Telehealth follow-up

Subscribe